Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis

Cornea2.80
Volume: 39, Issue: 8, Pages: 986 - 990
Published: Apr 5, 2020
Abstract
Purpose: Voriconazole was shown to inhibit ergosterol synthesis in various acanthamoeba species. The purpose of this study was to evaluate the clinical outcome of treatment with supplemental topical voriconazole in patients with acanthamoeba keratitis (AK). Methods: All patients who had been treated for AK with voriconazole 1% drops in conjunction with topical first-line antiacanthamoeba therapy composed of polyhexamethylene biguanide (PHMB)...
Paper Details
Title
Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis
Published Date
Apr 5, 2020
Journal
Volume
39
Issue
8
Pages
986 - 990
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.